Agios Interest Expense from 2010 to 2026
| 8AP Stock | EUR 25.00 0.60 2.34% |
Interest Expense | First Reported 2010-12-31 | Previous Quarter 0.0 | Current Value 0.0 | Quarterly Volatility 4.3 M |
Check Agios Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Agios Pharmaceuticals' main balance sheet or income statement drivers, such as Interest Expense of 0.0, Selling General Administrative of 116.6 M or Total Revenue of 65.8 M, as well as many indicators such as . Agios financial statements analysis is a perfect complement when working with Agios Pharmaceuticals Valuation or Volatility modules.
Agios | Interest Expense |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Agios Stock
Agios Pharmaceuticals financial ratios help investors to determine whether Agios Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Agios with respect to the benefits of owning Agios Pharmaceuticals security.